Basic principles in thrombolysis: regulatory role of plasminogen.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Thrombosis Research

• Publication date

  2001-09-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0049-3848(01)00296-1PMID 11567668
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Roles of protease-activated receptors in a mouse model of endotoxemia.

  2006cited by this paper
• Urokinase and Single-Chain Urokinase-Type Plasminogen Activator (Pro-urokinase)

  2001cited by this paper
• Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).

  2001cited by this paper
• Fibrinolytics and Antifibrinolytics

  2001cited by this paper
• Regulation of fibrinolytic activity by localization of inhibitors to fibrin(ogen)

  2000cited by this paper
• Recent developments in thrombolytic therapy

  2000cited by this paper
• Molecular transport during fibrin clot lysis

  2000cited by this paper
• An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.

  2000cited by this paper
• High levels of coagulation factor XI as a risk factor for venous thrombosis.

  2000cited by this paper
• Plasminogen-enriched pulse-spray thrombolysis with tPA: further developments.

  2000cited by this paper
• High accumulation of plasminogen and tissue plasminogen activator at the flow surface of mural fibrin in the human arterial system.

  2000cited by this paper
• Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic Pathway

  2000cited by this paper
• Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis.

  2000cited by this paper
• Consequences of inhibition of plasma carboxypeptidase B on in vivo thrombolysis, thrombosis and hemostasis

  2000cited by this paper
• A novel approach to arterial thrombolysis.

  1999cited by this paper
• Fibrin-specificity of a Plasminogen Activator Affects the Efficiency of Fibrinolysis and Responsiveness to Ultrasound: Comparison of Nine Plasminogen Activators In Vitro

  1999cited by this paper
• A Novel Approach to Arterial Thrombolysis

  1999cited by this paper
• Thrombolytic agents - An updated overview

  1998cited by this paper
• Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.

  1998cited by this paper
• A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor*

  1998cited by this paper
• Factor XI and Protection of the Fibrin Clot against Lysis – a Role for the Intrinsic Pathway of Coagulation in Fibrinolysis

  1998cited by this paper
• The plasma carboxypeptidases and the regulation of the plasminogen system.

  1997cited by this paper
• On the Mechanism of the Antifibrinolytic Activity of Plasma Carboxypeptidase B*

  1997influential reference
• The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent.

  1996cited by this paper
• An Antifibrinolytic Mechanism Describing the Prothrombotic Effect Associated with Factor VLeiden*

  1996cited by this paper
• Rearrangements of the Fibrin Network and Spatial Distribution of Fibrinolytic Components during Plasma Clot Lysis

  1996cited by this paper
• Interactions between Staphylokinase, Plasmin(ogen), and Fibrin

  1996cited by this paper
• Inducible carboxypeptidase activity. A role in clot lysis in vivo.

  1996cited by this paper
• Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma.

  1996cited by this paper
• Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.

  1995cited by this paper
• Superficial accumulation of plasminogen during plasma clot lysis.

  1995cited by this paper
• Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor (*)

  1995cited by this paper
• Activation and characterization of procarboxypeptidase B from human plasma.

  1995cited by this paper
• Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen.

  1994cited by this paper
• A faster-acting and more potent form of tissue plasminogen activator.

  1994cited by this paper
• Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis.

  1993cited by this paper
• Plasminogen: a structural review.

  1992cited by this paper
• "Plasminogen steal" and clot lysis.

  1992cited by this paper
• Influence of Intrinsic and Extrinsic Plasminogen upon the Lysis of Thrombi In Vitro

  1991cited by this paper
• Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma.

  1991cited by this paper
• Protein C and fibrinolysis: a link between coagulation and fibrinolysis.

  1990cited by this paper
• Purification and characterization of a new arginine carboxypeptidase in human serum.

  1990cited by this paper
• Paradoxical attenuation of fibrinolysis attributable to “plasminogen steal” and its implications for coronary thrombolysis

  1990cited by this paper
• An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits.

  1989cited by this paper
• Effect of Retraction on the Lysis of Human Clots with Fibrin Specific and Non-Fibrin Specific Plasminogen Activators

  1989cited by this paper
• Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.

  1988cited by this paper
• Review of studies with plasminogen concentrates and proposals for further therapeutic strategies with plasminogen concentrates.

  1988cited by this paper
• Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.

  1984cited by this paper

• The fibrinolytic system in disease: From molecular pathways to clinical outcomes.

  2025cites this paper
• Current Understandings on Biological Characteristics of Thrombolytics in Acute Ischemic Stroke

  2025influential citation
• Health and social inequalities in childhood associate with left ventricular diastolic dysfunction: A life-course EWAS of the 1946 Birth Cohort

  2025cites this paper
• The Emerging role of Lipoprotein(a) in diabetic kidney disease: possible pathophysiological links and unresolved mechanisms.

  2025cites this paper
• Alterations of perineuronal net expression and abnormal social behavior and whisker-dependent texture discrimination in mice lacking the autism candidate gene Engrailed 2.

  2024cites this paper
• Identification of plasminogen-binding sites in Streptococcus suis enolase that contribute to bacterial translocation across the blood-brain barrier

  2024cites this paper
• Proteoform-Resolved Profiling of Plasminogen Activation Reveals Novel Abundant Phosphorylation Site and Primary N-Terminal Cleavage Site

  2023cites this paper
• The Role of the Plasminogen/Plasmin System in Inflammation of the Oral Cavity

  2023influential citation
• Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States

  2022cites this paper
• Breaking the fibrinolytic speed limit with microwheel co-delivery of tissue plasminogen activator and plasminogen

  2021cites this paper
• The ANXA2/S100A10 Complex—Regulation of the Oncogenic Plasminogen Receptor

  2021cites this paper
• Tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in patients with symptomatic lower extremity artery disease.

  2020cites this paper
• Physiology of Haemostasis: Plasmin-Antiplasmin System

  2020cites this paper
• Hypochlorite-Induced Damage of Plasminogen Molecules: Structural-Functional Disturbance

  2019cites this paper
• Targeting cell signaling in allergic asthma

  2019cites this paper
• Soy isoflavones reduce asthma exacerbation in asthmatic patients with high PAI-1-producing genotypes.

  2019cites this paper
• Physiology, Plasminogen Activation

  2019cites this paper
• [Thrombolytic therapy of ischemic stroke].

  2018cites this paper
• Networks of blood proteins in the neuroimmunology of schizophrenia

  2018cites this paper
• A novel mechanism of plasminogen activation in epithelial and mesenchymal cells

  2018cites this paper
• Effect of Specific Cleavage of Immunoglobulin G by Plasmin on the Binding and Activation of Plasminogen

  2018cites this paper
• Role of Proteases in Lung Disease: A Brief Overview

  2017cites this paper
• Plasmin-Antiplasmin System

  2016cites this paper
• Implication du remodelage de l'unité neurovasculaire dans la maladie d'Alzheimer : l'hypoperfusion cérébrale et le système de l'activateur tissulaire du plasminogène

  2016cites this paper
• Plasminogen activator inhibitor-1 in black South Africans, methodological and clinical considerations

  2016cites this paper
• Synergistic fibrinolysis: The combined effects of tissue plasminogen activator and recombinant staphylokinase in vitro.

  2016cites this paper
• Stressed neurons protect themselves by a tissue-type plasminogen activator-mediated EGFR-dependent mechanism

  2015cites this paper
• Streptokinase and staphylokinase: Differences in the kinetics and mechanism of their interaction with plasminogen, inhibitors, and fibrin

  2015cites this paper
• Cross-talk between human mast cells and bronchial epithelial cells in plasminogen activator inhibitor-1 production via transforming growth factor-β1.

  2015cites this paper
• The Dual Role of Serpins and Tissue-Type Plasminogen Activator During Stroke

  2015cites this paper
• [Structure and functions of plasminogen/plasmin system].

  2014cites this paper
• The association between fibrinolysis markers and body composition in black adults in the North West Province of South Africa

  2014cites this paper
• Isolation of Fibrinolytic Yeasts from Korean Traditional Fermented Soybean

  2014cites this paper
• Cross-Talk between Human Mast Cells and Bronchial Epithelial Cells in Plasminogen Activator Inhibitor-1 Production via Transforming Growth Factor- b 1

  2014cites this paper
• Structure and function of plasminogen/plasmin system

  2014cites this paper
• Caractérisation par IRM précoce de la synergie tPA - inhibiteur du TAFI dans un modèle d'ischémie focale thromboembolique murin

  2013cites this paper
• Stability of Tranexamic Acid after 12-Week Storage at Temperatures from –20°C to 50°C

  2013cites this paper
• Global fibrinolytic potential of black South Africans in the North West Province

  2013influential citation
• Mechanistic studies on human fibrinogen polymorphisms that influence blood clot formation and lysis

  2013cites this paper
• Chapter 5 – Normal Mechanisms of Vascular Hemostasis

  2013cites this paper
• Novos conceitos sobre a fisiologia da hemostasia

  2012cites this paper
• Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis.

  2012cites this paper
• The short term effects of Endovascular Aneurysm Repair (EVAR) on coagulation and cardiovascular morbidity and mortality in patients with infra-renal Abdominal Aortic Aneurysms

  2012cites this paper
• Role of fibrin structure in thrombosis and vascular disease.

  2011cites this paper
• Tripeptides with C-Terminal Arginine as Potential Inhibitors of Urokinase

  2011cites this paper
• Impact of Tissue Plasminogen Activator on the Neurovascular Unit: From Clinical Data to Experimental Evidence

  2011cites this paper
• Mechanism of the inhibitory effect of angiostatin on plasminogen activation by its physiologic activators

  2011cites this paper
• Incidence of Venous Thromboembolic Disease

  2009influential citation
• A kringle-containing protease with plasminogen-like activity in the basal chordate Branchiostoma belcheri.

  2009cites this paper
• Preoperative predictors of postsurgical adhesion formation and the Prevention of Adhesions with Plasminogen Activator (PAPA-study): results of a clinical pilot study.

  2009cites this paper
• Effect of Reteplase™ and PAI-1 antibodies on postoperative adhesion formation in a laparoscopic mouse model

  2009cites this paper
• New insights into the molecular mechanisms of the fibrinolytic system

  2009cites this paper
• Decrease of Fibrinolytic Potential in the Occurence of Cerebral Ischemia

  2008cites this paper
• Self-assembled DNA nanostructures: From structural material to biomedical nanodevices

  2008cites this paper
• Deep vein thrombosis of lower extremity: direct intraclot injection of alteplase once daily with systemic anticoagulation--results of pilot study.

  2008cites this paper
• Protease Activation and Inflammation in Acute Pancreatitis

  2008cites this paper
• Hypochlorous acid is a potent inactivator of human plasminogen at concentrations secreted by activated granulocytes

  2008cites this paper
• DECREASE OF FIBRINOLYTIC POTENTIAL IN THE OCCURENCE OF CEREBRAL ISCHEMIA UTICAJ PADA FIBRINOLIZNOG POTENCIJALA NA NASTANAK CEREBRALNE ISHEMIJE

  2008cites this paper
• Pathophysiology and prevention of adhesion formation in a laparoscopic mouse model

  2008cites this paper
• Mechanism of action of omega-amino acids on plasminogen activation and fibrinolysis induced by staphylokinase.

  2007cites this paper
• The effects of plasminogen deficiency on the healing of tympanic membrane perforations

  2007cites this paper
• Mechanism of action of θ-amino acids on plasminogen activation and fibrinolysis induced by staphylokinase

  2007cites this paper
• PAK: an essential motif for forming beta-turn structures and exhibiting the thrombolytic effect of P6A and its analogs.

  2007cites this paper
• Spontaneous development of otitis media in plasminogen-deficient mice.

  2006cites this paper
• Functional studies of purifi ed transmembrane proteases, omptins, of Yersinia pestis and Salmonella enterica.

  2006cites this paper
• chapter 4 – Normal Mechanisms of Hemostasis

  2006cites this paper
• Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects.

  2006cites this paper
• Functional phenotyping of human plasma using a 361‐fluorogenic substrate biosensing microarray

  2006cites this paper
• Stimulation of tPA-dependent provisional extracellular fibrin matrix degradation by human recombinant soluble melanotransferrin.

  2006cites this paper
• MULTIFUNCTIONAL ROLES OF PLASMIN IN INFLAMMATION Studies of animal models on rheumatoid arthritis, multiple sclerosis, wound healing and infection

  2005cites this paper
• Thrombolysis: Scientific Basis for Current Therapy

  2005cites this paper
• The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo.

  2005cites this paper
• The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management?

  2004cites this paper
• Activation of plasminogen by Streptococcus mutans.

  2004cites this paper
• Fisiopatologia della coagulazione: nuove acquisizioni.

  2004cites this paper
• The roles of the plasminogen activator and matrix metalloproteinase systems in ovulation and corpus luteum formation

  2004cites this paper
• TAFI: a promising drug target?

  2004cites this paper
• Enhancement of Fibrinolysis by EF6265 [(S)-7-Amino-2-[[[(R)-2-methyl-1-(3-phenylpropanoylamino)propyl]hydroxyphosphinoyl] methyl]heptanoic Acid], a Specific Inhibitor of Plasma Carboxypeptidase B

  2004cites this paper
• Synergy of in vitro Thrombolytic Action of Combinations of Recombinant Staphylokinase and Single-Chain Urokinase-Type Plasminogen Activator

  2003cites this paper
• Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFI

  2003cites this paper
• Carboxypeptidase B inhibitors reduce tissue factor-induced renal microthrombi in rats.

  2003cites this paper
• Can the Time Window for Administration of Thrombolytics in Stroke be Increased?

  2003cites this paper
• Fibrinolyse et fibrinogénolyse en réanimation

  2002cites this paper
• Localization of Regulatory Elements Mediating Constitutive and Cytokine-stimulated Plasminogen Gene Expression*

  2002cites this paper
• Plasminogen activators in inflammation and sepsis.

  2002cites this paper
• Alterations of Perineuronal Net Expression and Abnormal Social 4 Behavior and Whisker-dependent Texture Discrimination in Mice

  year unknowncites this paper